Woodline Partners LP Corcept Therapeutics Inc Transaction History

Woodline Partners LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$19.95 - $29.96 $11 Million - $16.5 Million	550,417 Added 152.06%	912,391 $18.5 Million
Q3 2022 Nov 14, 2022	BUY	$24.7 - $29.12 $8.94 Million - $10.5 Million	361,974 New	361,974 $9.28 Million
Q3 2021 Nov 15, 2021	SELL	$19.68 - $22.53 $4.19 Million - $4.8 Million	-213,080 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$19.97 - $24.43 $4.9 Million - $6 Million	-245,421 Reduced 53.53%	213,080 $4.69 Million
Q1 2021 May 17, 2021	SELL	$23.49 - $30.56 $2.52 Million - $3.28 Million	-107,391 Reduced 18.98%	458,501 $10.9 Million
Q4 2020 Feb 16, 2021	BUY	$16.78 - $27.3 $9.5 Million - $15.4 Million	565,892 New	565,892 $14.8 Million

350

86.1M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $5.92B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

Stay updated on Woodline Partners LP with notifications on news.